ProPhase Labs, Inc.
PRPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $14 | $39 | $76 | $54 |
| - Cash | $1 | $2 | $9 | $8 |
| + Debt | $25 | $21 | $7 | $15 |
| Enterprise Value | $38 | $59 | $74 | $61 |
| Revenue | $7 | $44 | $123 | $79 |
| % Growth | -84.7% | -63.8% | 55.2% | – |
| Gross Profit | -$0 | $16 | $71 | $33 |
| % Margin | -2.2% | 36.6% | 57.6% | 41.5% |
| EBITDA | -$32 | -$15 | $29 | $11 |
| % Margin | -477.6% | -33.4% | 23.4% | 14.4% |
| Net Income | -$53 | -$17 | $18 | $6 |
| % Margin | -788.2% | -37.8% | 15.1% | 7.9% |
| EPS Diluted | -2.61 | -0.98 | 1.02 | 0.4 |
| % Growth | -166.3% | -196.1% | 155% | – |
| Operating Cash Flow | -$18 | -$11 | $29 | -$14 |
| Capital Expenditures | -$1 | -$3 | -$4 | -$4 |
| Free Cash Flow | -$18 | -$15 | $25 | -$18 |